glp 1 intermittent fasting Danger! The truth about on a GLP-1 Intermittent Fasting for Women and

This is where orlistats distinctive side effect profile comes from and why dietary compliance matters so much with this medication

It was a masterclass in how to translate complicated science into patient-centered care

The most common adverse events reported in clinical trials are gastrointestinal in nature, as the medication works by slowing down your digestive system

Phase 3 Update: TRIUMPH-4 Results Preliminary data from the ongoing Phase 3 TRIUMPH-4 trial (68 weeks) shows higher numbers than Phase 2: 12mg dose: 28.7% average weight loss (~71 lbs / 32 kg) 9mg dose: 26.4% average weight loss (~64 lbs / 29 kg) Knee osteoarthritis pain: 76% reduction (significant quality-of-life improvement) Blood pressure: Average reduction of 14 mmHg Full Phase 3 results across the TRIUMPH program (obesity, diabetes, cardiovascular outcomes, kidney outcomes) are expected throughout 2026